Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by WomansStockingson May 14, 2010 3:25pm
364 Views
Post# 17100634

RE: RE: Where are our t/a guys? THE FAX nothing bu

RE: RE: Where are our t/a guys? THE FAX nothing bu
BuySell STEM CELL THERAPEUTICS CORP 3:25:12 PM EDT
Symbol T Bid Ask Last Change Volume FSI
SSS CA V + 0.435 0.44 0.44 -0.04 (-8.33%) 1,589,491
Bid Size 106 Ask Size 17 Earn. Per Share -0.05
Day High 0.48 Day Low 0.435 Price/Earnings 0
Open 0.48 Yield 0.00 Dividend 0.00
52 Week High 0.55 52 Week Low 0.075 Ex-Dividend


donate to STEM SELL RESEARCH
Bullboard Posts